NCT03365908
Pain Management of ACL Reconstruction
Enrolling by Invitation
NAAges 18–45InterventionalTreatmentUniversity of California, DavisInvestigator-initiated
~60 participants
Updated 2025-12-02 on ClinicalTrials.gov
What's tested:Adductor Canal Nerve BlockRopivacaine injection
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Immediate Post-op Pain Score
Measured over 15 min post-op
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Cassandra Lee, MD · PRINCIPAL_INVESTIGATOR · UC-Davis Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Between the ages of 18 and 45 years old.
Clinical and/or advanced imaging confirmation of ACL tear of which reconstructive surgery is recommended and accepted.
Exclusion
No prior surgery of the affected and contralateral knee
Adults unable to consent
Children (age \< 18 years old)
Prisoners
Pregnant women
Inflammatory arthritis
Non-English-speaking patients
What this trial measures
- Immediate Post-op Pain Score15 min post-op
Measured via Visual Analog Scale (VAS) in recovery, scale from 0 (least) to 10 (maximum), no units, with 0 being no pain and 10 being extreme pain
- Opioid Use6 weeks post-op
Aggregated amount of narcotic medication used, measured in milligrams